AZ
AstraZeneca and Harvard team up for diabetes research
March 25, 2015Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic
AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …
AstraZeneca signs $240m asthma deal with UK biotech
June 12, 2014Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen
UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …
GSK signs Adaptimmune deal
June 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology
GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …
Pfizer admits AstraZeneca defeat
May 27, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, Pfizer, Read, buyout, merger
Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …
‘Stop Alzheimer’s testing on animals’
May 22, 2014Research and Development, Sales and Marketing AZ, Alzheimer's, Pfizer, humane, langley
Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …
Pfizer grilled by MPs – but AZ revelations shock
May 14, 2014Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover
The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …
‘Bioscience is cornerstone’ of Alderley Park
May 12, 2014Research and Development, Sales and Marketing AZ, AstraZeneca, alderley, msp, research
Manchester Science Parks (MSP), the new owners of the 400-acre Alderley Park facility, has pledged to keep its activities “at …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
BMS revenue drops in 2013
January 27, 2014Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4
Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …
FDA seeks top-to-toe review of Wockhardt manufacturing
December 9, 2013Manufacturing and Production AZ, GMP, Taylor, Wockhardt. fda
Wockhardt has been asked to undertake an assessment of its entire manufacturing processes, according to an FDA warning letter. Sent …
EFPIA slams EMA data proposals
September 10, 2013Research and Development, Sales and Marketing AZ, EFPIA, EMA, GSK, Pfizer, Roche
The intense debate over how pharma should make trial data available has taken another turn as a major European industry …
Proveca appoints former ABPI and AZ president
September 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AZ, Brinsmead, Proveca
The former president of AstraZeneca and the ABPI has been appointed as chairman of pharma firm Proveca. Chris Brinsmead joins …
AZ and BMS go for second Forxiga submission
July 29, 2013Sales and Marketing AZ, BMS, FDA, Forxiga
AstraZeneca and partner Bristol-Myers Squibb have resubmitted their diabetes drug Forxiga to the FDA 18 months after it was rejected …
AstraZeneca launches prostate cancer app
August 7, 2012Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate
AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
